Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident

NCT ID: NCT04694001

Last Updated: 2022-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-12

Study Completion Date

2022-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The INSPIRE study is interventional, European, prospective, open, multicentric, each patient being his/her own control.

It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting an hemiplegia due to cerebrovascular accident. The primary endpoint is defined by the reported adverse events.

The study will include 40 patients and takes place in six rehabilitation centers (4 in France, 1 in Luxembourg, 1 in Belgium).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Stroke, Acute Stroke, Subacute Chronic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemiplegia due to Cerebrovascular Accident (CVA)

Group Type OTHER

Use of the Atalante exoskeleton

Intervention Type DEVICE

A session includes stand-up, walks, exercises with or without the assistance of the exoskeleton, rotation, side and back step, squat and sitting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of the Atalante exoskeleton

A session includes stand-up, walks, exercises with or without the assistance of the exoskeleton, rotation, side and back step, squat and sitting.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with hemiplegia due to cerebrovascular accident, occurred two weeks ago or more, follow up in a rehabilitation center or in a hospital (inpatient or outpatient),
* Patient presenting a FAC score of 0, 1, 2 or 3,
* Patient whose etiological evaluation of the stroke has been complete,
* Adult patient ≥18 years old,
* Patient able to read and write in at least one of the languages of the country and who have signed an informed consent form.

Exclusion Criteria

* Individuals with severe spasticity of adductor muscles, hamstring, quadriceps and triceps surae. Severe spasticity is defined by a score greater than 3 on the modified Ashworth scale,
* Pregnant women
* Individuals with history of osteoporotic fracture and pathology or treatment causing secondary osteoporosis,
* Pressure Ulcer of Grade I or higher according to the National Pressure Ulcer Advisory Panel (NPUAP) International Pressure Ulcer Classification System- European Pressure Ulcer Advisory Panel (EPUAP), in areas of contact with the Atalante system,
* Severe aphasia limiting ability to express needs or to fulfil questionnaires, at the discretion of the physician.
* Patient with a cardiac or respiratory contraindication to physical exertion,
* Patient with a score below 18 on the Mini Mental State test,
* Patient unable to deliver his/her consent,
* Patient under legal protection,
* Patient participating at the same time in another study,
* Patients with morphological contraindications to the use of the Atalante exoskeleton.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wandercraft

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques universitaires Saint-Luc

Brussels, , Belgium

Site Status

Centre Jacques Calvé - Fondation Hopale

Berck, , France

Site Status

Centre de Médecine Physique et de Réadaptation

Pionsat, , France

Site Status

Centre mutualiste de Rééducation et de Réadaptation de Kerpape

Ploemeur, , France

Site Status

Hôpital La Musse, La Renaissance Sanitaire

Saint-Sébastien-de-Morsent, , France

Site Status

Rehazenter

Luxembourg, , Luxembourg

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France Luxembourg

References

Explore related publications, articles, or registry entries linked to this study.

Lejeune T, Nuic D, Dehem S, Previnaire JG, Cuenot C, Debugne T, Kaps J, Paul B, Pean V, Perez SS, Juhel F, Tatsidou S, Kerdraon J. Hands-free Atalante exoskeleton in post-stroke gait and balance rehabilitation: a safety study. J Neuroeng Rehabil. 2025 Apr 12;22(1):82. doi: 10.1186/s12984-025-01621-z.

Reference Type DERIVED
PMID: 40221748 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INSPIRE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Minor Stroke Therapy Evaluation
NCT03796468 RECRUITING NA